Skip to main content
Livermore
Livermore
ZHEN

TFF Pharmaceuticals, Inc.

TFFPDelisted Mar 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001733413

TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding TFF Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of TFFP: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders45145+1
Shares4.19M1.00M4.23M+1.04M (+32.7%)
Value$23.7M$5.65M$17.2M−$837.0K (−4.6%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held TFF Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TFFP in Q3 2022
InstitutionSharesValue% of portfolio
DRW Securities, L.L.C.1,000,000$4.06M1.27%
Virtu Financial LLC20,776$84.0K0.01%
Venturi Wealth Management, LLC8,273$34.0K0.00%
Caption Management, LLC5,000$21.0K0.00%
Simplex Trading, LLC3,213$13.0K0.00%
Advisor Group Holdings, Inc.1,000$4.00K0.00%

Sold out (5)

Institutions that held TFF Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of TFFP in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Gsa Capital Partners LLP93,679$529.0K
JPMorgan Chase & Co43,133$244.0K
Group One Trading, L.P.37,273$211.0K
PDT Partners, LLC17,051$96.0K
Citigroup Inc500$3.00K

Not filed for Q3 2022 yet (1)

Institutions that held TFF Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TFFP in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
DRW Securities, LLC1,000,000$5.65M